Summary: For people with retinitis pigmentosa, vision loss often progresses like an unrelenting clock. New research from Cedars-Sinai reveals how transplanted human neural progenitor cells preserve vision: rather than simply replacing lost tissue, these cells function as a versatile repair system. Using single-cell transcriptomic analysis, investigators show transplanted cells deliver protective proteins, reduce cellular stress, and remodel the retinal environment to support surviving cells.
In rodent models of retinal degeneration, a single subretinal transplant of neural progenitor cells halted vision decline for up to 180 days—an interval that researchers equate to roughly 20 years of protection in human terms. The study maps how grafted cells and host retinal cells interact and adapt over time, providing a detailed biological blueprint for advancing cell-based therapies for degenerative eye disease.
Key Facts
- Multifaceted repair: Transplanted neural progenitor cells protect photoreceptors through multiple mechanisms, including secretion of trophic factors, modulation of metabolism, suppression of apoptosis and oxidative stress, and remodeling of the extracellular matrix.
- Long-term protection in models: In rat models of retinitis pigmentosa, a single graft preserved retinal function for up to 180 days, an interval the authors compare to many human years.
- Dynamic interactions: The relationship between graft-derived cells and host retinal cells evolves over time, with grafts differentiating toward an astroglial phenotype and altering the signaling environment.
- Single-cell resolution: Advanced single-cell transcriptomics allowed researchers to track temporal changes in gene expression in both grafted and host cells and to identify key protective pathways.
- Future directions: Results highlight specific trophic factors—particularly MANF—as promising targets, and investigators are engineering neural progenitor cells to express protective proteins to enhance therapeutic benefit.
Source: Cedars-Sinai
Cedars-Sinai researchers optimizing a cell-based approach for retinitis pigmentosa have described how transplanted human neural progenitor cells interact with host retinal tissue to preserve vision.
Published in Nature Communications, the study provides a detailed temporal map of gene expression changes in grafted cells and the host retina, offering insight into how cell-based therapies slow degeneration and support remaining photoreceptors.
“Using single-cell analysis, we found that neural progenitor cells protect vision through several coordinated strategies: supplying protective proteins, restoring retinal cells toward healthier states, lowering cellular stress, and maintaining retinal structure,” said Clive Svendsen, PhD, executive director of the Board of Governors Regenerative Medicine Institute and co-corresponding author of the study.
In the experiments, human neural progenitor cells (hNPCs) were injected into the subretinal space of rats with retinal degeneration. Prior work from the group demonstrated strong functional benefit in these animals for months after a single graft. This study focused on characterizing how grafted cells and host retinal cells communicate and change over time to sustain that benefit.
“Our data reveal that interactions between grafted cells and the host retina are not static,” said Shaomei Wang, MD, PhD, professor of Biomedical Sciences and co-corresponding author. “Grafted cells mature and adopt an astroglial phenotype, and signaling networks shift as the retinal environment changes. Understanding these dynamics points to ways we can improve and extend therapy.”
The team observed that grafted hNPCs contribute to photoreceptor protection through trophic factor secretion, metabolic support, suppression of apoptosis and inflammation, and extracellular matrix remodeling. Computational cell–cell signaling analysis indicated that communication strength between graft and host declines over time, suggesting that enhancing sustained trophic support could extend therapeutic durability.
Based on these findings, investigators are engineering neural progenitor cells to overexpress key protective proteins highlighted by the study, aiming to strengthen and prolong the beneficial effects on the host retina.
Additional Cedars-Sinai contributors include Saba Shahin, Shaughn Bell, Bin Lu, Hui Xu, Jason Chetsawang, Stephany Ramirez, Jorge S. Alfaro, Alexander Laperle and Soshana Svendsen. Other co-authors include Somanshu Banerjee and Vivek Swarup.
Funding: Supported by the California Institute for Regenerative Medicine (LSP1-08235). Individual support included CIRM-EDUC awards and funding from the Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center.
Key Questions Answered
A: The study stops short of claiming a cure. Instead, it demonstrates that grafted neural progenitor cells can significantly slow or halt progression in a model of degenerative retinal disease. The cells act as a supportive, dynamic maintenance system that preserves existing vision rather than fully reversing severe, established blindness.
A: The grafted cells are active and adaptive: they secrete trophic factors, modulate host cell metabolism, and reduce stressors that drive cell death. Over time the grafted cells mature and continuously adjust their responses to the retinal environment, acting like an ongoing repair crew.
A: Translating from animal models to human trials is already an area of active research. By identifying specific protective proteins and signaling pathways involved in preservation, investigators can design enhanced cell therapies for clinical testing. Timelines depend on preclinical validation and regulatory pathways.
Editorial Notes
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by editorial staff.
- Additional context was added by the reporting team.
About this genetics and visual neuroscience research news
Author: Cara Martinez
Source: Cedars-Sinai
Contact: Cara Martinez, Cedars-Sinai
Image: The image is credited to Neuroscience News
Original Research: Open access. “Dynamic transcriptomic remodeling in grafted human neural progenitor cells uncovers mechanisms for vision preservation in a rat model of retinitis pigmentosa” by Saba Shahin, Shaughn Bell, Bin Lu, Somanshu Banerjee, Vivek Swarup, Hui Xu, Jason Chetsawang, Stephany Ramirez, Jorge S. Alfaro, Alexander Laperle, Soshana Svendsen, Clive N. Svendsen & Shaomei Wang. Nature Communications. DOI: 10.1038/s41467-026-69776-4
Abstract
Dynamic transcriptomic remodeling in grafted human neural progenitor cells uncovers mechanisms for vision preservation in a rat model of retinitis pigmentosa
Human neural progenitor cells (hNPCs) are a promising approach for slowing retinal degeneration and are being evaluated in clinical studies for retinitis pigmentosa. However, the long-term fate of grafted hNPCs and how they interact with host retinal cells have not been fully defined.
This study applied single-cell transcriptomics to measure time-dependent gene expression changes in grafted hNPCs and host retinal cells after subretinal transplantation in a rodent model of retinal degeneration. The analysis reveals dynamic remodeling of transcriptional programs in both graft and host cells within the degenerative environment.
Grafted hNPCs predominantly acquire an astroglial phenotype as they mature and support photoreceptors through secretion of trophic factors, metabolic modulation, suppression of apoptosis, reduction of oxidative stress and inflammation, and extracellular matrix remodeling. Network analysis indicates that intercellular signaling strength between graft and host declines over time, suggesting opportunities to enhance sustained trophic support—particularly via factors such as MANF—to prolong vision preservation.